Show simple item record

dc.contributor.authorGenga, E
dc.contributor.authorOyoo, O
dc.contributor.authorAdebajo, A
dc.date.accessioned2018-07-30T06:45:37Z
dc.date.available2018-07-30T06:45:37Z
dc.date.issued2018
dc.identifier.citationCurr Rheumatol Rep. 2018 Feb 21;20(2):4.en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/29464351
dc.identifier.urihttp://hdl.handle.net/11295/103496
dc.description.abstractPURPOSE OF REVIEW: Systemic vasculitides are characterized by inflammation of blood vessel walls leading to a myriad of organ disorders depending on the size, site, and location of the affected blood vessel. The epidemiology of vasculitis in the developing world has been inadequately documented. The description of the vasculitides in Africa, both from hospital series as well as taking into consideration, previous epidemiological studies in the community, indicates that these conditions have been rare until relatively recently. In view of these past observations, this review of publications on the topic looks to shed light on the current state of vasculitis in Africa. RECENT FINDINGS: Takayasu and Kawasaki appear to be the most commonly reported vasculitides in Africa. Most of the published reports are from North and South Africa. Furthermore, the contribution of vasculitis associated with infections, and in particular HIV, is significant. There are increasing numbers of publications reflecting a growing recognition of the vasculitides in Africa.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectAfrica; Vasculitides; Vasculitisen_US
dc.titleVasculitis in Africaen_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States